Scientists scan brains for clues to Parkinson's progression
NCT ID NCT04735172
Summary
This study aims to better understand the brain chemistry of Parkinson's disease in its earliest stages. Researchers will use a powerful, specialized MRI scanner to measure levels of specific chemicals in the brains of people who have been recently diagnosed and are not yet on medication, comparing them to healthy volunteers. The goal is to identify chemical changes that might explain how Parkinson's starts and progresses, which could inform future treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON'S DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU Poitiers
RECRUITINGPoitiers, France
Contact
-
Chu Clermont Ferrand
NOT_YET_RECRUITINGClermont-Ferrand, 63003, France
Contact
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.